178 related articles for article (PubMed ID: 27876303)
1. Rapid visualization of nonmelanoma skin cancer.
Walker E; Mann M; Honda K; Vidimos A; Schluchter MD; Straight B; Bogyo M; Popkin D; Basilion JP
J Am Acad Dermatol; 2017 Feb; 76(2):209-216.e9. PubMed ID: 27876303
[TBL] [Abstract][Full Text] [Related]
2. Mohs micrographic surgery: a cost analysis.
Cook J; Zitelli JA
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
[TBL] [Abstract][Full Text] [Related]
3. Laboratory errors leading to nonmelanoma skin cancer recurrence after Mohs micrographic surgery.
Zabielinski M; Leithauser L; Godsey T; Gloster HM
Dermatol Surg; 2015 Aug; 41(8):913-6. PubMed ID: 26218725
[TBL] [Abstract][Full Text] [Related]
4. A Protease-Activated Fluorescent Probe Allows Rapid Visualization of Keratinocyte Carcinoma during Excision.
Walker E; Liu Y; Kim I; Biro M; Iyer SR; Ezaldein H; Scott J; Merati M; Mistur R; Zhou B; Straight B; Yim JJ; Bogyo M; Mann M; Wilson DL; Basilion JP; Popkin DL
Cancer Res; 2020 May; 80(10):2045-2055. PubMed ID: 32132111
[TBL] [Abstract][Full Text] [Related]
5. Optical mapping of nonmelanoma skin Cancers-A pilot clinical study.
Yaroslavsky AN; Feng X; Neel VA
Lasers Surg Med; 2017 Nov; 49(9):803-809. PubMed ID: 28543587
[TBL] [Abstract][Full Text] [Related]
6. The Skin Cancer Index: quality-of-life outcomes of treatments for nonmelanoma skin cancer.
Sanchez N; Griggs J; Nanda S; Fayne R; Castillo D; De Bedout V; Meirson D; Nichols A
J Dermatolog Treat; 2020 Aug; 31(5):491-493. PubMed ID: 31566077
[No Abstract] [Full Text] [Related]
7. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.
Rogers HW; Coldiron BM
J Am Acad Dermatol; 2009 Jul; 61(1):96-103. PubMed ID: 19539843
[TBL] [Abstract][Full Text] [Related]
8. Correlation Between Incisional Biopsy Histological Subtype and a Mohs Surgery Specimen for Nonmelanoma Skin Cancer.
Cortés-Peralta EC; Ocampo-Candiani J; Vázquez-Martínez OT; Gutiérrez-Villarreal IM; Miranda-Maldonado I; Garza-Rodríguez V
Actas Dermosifiliogr (Engl Ed); 2018; 109(1):47-51. PubMed ID: 29066323
[TBL] [Abstract][Full Text] [Related]
9. Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study.
Jih MH; Friedman PM; Goldberg LH; Kimyai-Asadi A
Dermatol Surg; 2005 Jan; 31(1):10-5. PubMed ID: 15720088
[TBL] [Abstract][Full Text] [Related]
10. Nonmelanoma Skin Cancer With Aggressive Subclinical Extension in Immunosuppressed Patients.
Song SS; Goldenberg A; Ortiz A; Eimpunth S; Oganesyan G; Jiang SI
JAMA Dermatol; 2016 Jun; 152(6):683-90. PubMed ID: 26981734
[TBL] [Abstract][Full Text] [Related]
11. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery.
Lane JE; Kent DE
Curr Surg; 2005; 62(5):518-26. PubMed ID: 16125611
[TBL] [Abstract][Full Text] [Related]
12. Margin Reanalysis With 3-Dimensional Micrographic Surgery Technique of Conventional Excision Specimens With Negative Margin Readings.
Magliano J; Navarrete J; Lezue V; González A; Martínez M; Bazzano C
Am J Dermatopathol; 2021 Jul; 43(7):485-488. PubMed ID: 32956098
[TBL] [Abstract][Full Text] [Related]
13. Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota.
Brewer JD; Shanafelt TD; Khezri F; Sosa Seda IM; Zubair AS; Baum CL; Arpey CJ; Cerhan JR; Call TG; Roenigk RK; Smith CY; Weaver AL; Otley CC
J Am Acad Dermatol; 2015 Feb; 72(2):302-9. PubMed ID: 25479909
[TBL] [Abstract][Full Text] [Related]
14. Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee.
Leitenberger JJ; Rogers H; Chapman JC; Maher IA; Fox MC; Harmon CB; Bailey EC; Odland P; Wysong A; Johnson T; Wisco OJ
J Am Acad Dermatol; 2016 Nov; 75(5):1022-1031. PubMed ID: 27546292
[TBL] [Abstract][Full Text] [Related]
15. Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery.
Schinstine M; Goldman GD
J Am Acad Dermatol; 2001 Mar; 44(3):497-9. PubMed ID: 11209121
[TBL] [Abstract][Full Text] [Related]
16. Use of Digitally Stained Multimodal Confocal Mosaic Images to Screen for Nonmelanoma Skin Cancer.
Mu EW; Lewin JM; Stevenson ML; Meehan SA; Carucci JA; Gareau DS
JAMA Dermatol; 2016 Dec; 152(12):1335-1341. PubMed ID: 27603676
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Inflammation in Frozen Sections With Site of Nonmelanoma Skin Cancer.
Alam M; Khan M; Veledar E; Pongprutthipan M; Flores A; Dubina M; Nodzenski M; Yoo SS
JAMA Dermatol; 2016 Feb; 152(2):173-6. PubMed ID: 26579703
[TBL] [Abstract][Full Text] [Related]
18. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
[TBL] [Abstract][Full Text] [Related]
19. Survival Outcomes of Mohs Surgery versus Wide Local Excision for Less Common Nonmelanoma Skin Cancers: A Stabilized Inverse Probability of Treatment Weighting Analysis.
Chen M; Yunqiong Wang Y
Dermatology; 2023; 239(6):877-888. PubMed ID: 37699383
[TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of Mohs micrographic surgery: review of the literature.
Tierney EP; Hanke CW
J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
